1/3
Read key takeaways from the proposed rule and access our updated, interactive data dashboard.
2/3
In this +Insight, we examine how CMS is using MA encounter data today, where policymakers may take it next, and what providers, health plans, life sciences companies, and other healthcare stakeholders should be watching as this increasingly important dataset continues to evolve.
3/3
Read key takeaways from the proposed rule and access our updated, interactive data dashboard.
